Welcome to our dedicated page for Wearable Devices SEC filings (Ticker: WLDSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission primarily through Form 20-F and Form 6-K filings. On Stock Titan’s WLDSW SEC filings page, investors can review these regulatory documents alongside AI-generated summaries that clarify the key points in each report.
The company’s Form 6-K current reports often include details of capital-raising transactions, such as registered direct offerings of ordinary shares, pre-funded warrants, and ordinary warrants, as well as warrant inducement agreements. These filings typically describe purchase agreements, placement agency agreements, exercise prices, and registration commitments related to new securities. Other 6-Ks incorporate press releases about patents, product developments, and clinical or commercial milestones, making them an important source for understanding material events.
Wearable Devices also uses its SEC filings to file financial statements and management’s discussion and analysis for interim periods, and to update information about equity incentive plans and share reserves. Many of these reports are expressly incorporated by reference into existing registration statements on Form F-3 and Form S-8, which are also identified in the filings.
On this page, Stock Titan provides real-time access to new WLDSW filings from EDGAR, along with AI-powered explanations that break down complex legal and financial language into more accessible summaries. Users can quickly locate filings that relate to warrant terms, equity offerings, incentive plans, and other corporate actions, and can explore how these disclosures fit into the company’s broader strategy in AI-powered neural input wearables. This resource helps investors and researchers interpret the regulatory record of Wearable Devices Ltd. without reading every filing in full.
Wearable Devices Ltd. entered a warrant inducement transaction with an institutional investor, raising approximately $5.0 million in gross cash proceeds through the cash exercise of existing warrants at a reduced price of $1.73 per ordinary share.
In return, the company issued new unregistered warrants to purchase up to 5,082,873 ordinary shares at an exercise price of $1.51 per share, exercisable immediately for five years. The company plans to use the net proceeds for working capital and general corporate purposes and agreed to register the resale of the new warrant shares and observe a 30‑day restriction on additional issuances, new registrations, and variable rate transactions, subject to stated exceptions.
Wearable Devices Ltd. entered a warrant inducement transaction with an institutional investor, raising approximately $5.0 million in gross cash proceeds through the cash exercise of existing warrants at a reduced price of $1.73 per ordinary share.
In return, the company issued new unregistered warrants to purchase up to 5,082,873 ordinary shares at an exercise price of $1.51 per share, exercisable immediately for five years. The company plans to use the net proceeds for working capital and general corporate purposes and agreed to register the resale of the new warrant shares and observe a 30‑day restriction on additional issuances, new registrations, and variable rate transactions, subject to stated exceptions.
Wearable Devices Ltd. director Bachar Eli filed an initial ownership report showing direct holdings in both ordinary shares and stock options. He reports 37,884 Ordinary Shares held directly, plus stock options over 768 Ordinary Shares at an exercise price of $0.7200 per share expiring on November 27, 2027, and options over 83 Ordinary Shares at an exercise price of $316.8000 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives, including 7,500 Ordinary Shares issuable from 2,500 restricted share units vesting through October 10, 2028, and 28,333 Ordinary Shares issuable from other restricted share units vesting in 34 monthly installments through January 1, 2029.
Wearable Devices Ltd. director Bachar Eli filed an initial ownership report showing direct holdings in both ordinary shares and stock options. He reports 37,884 Ordinary Shares held directly, plus stock options over 768 Ordinary Shares at an exercise price of $0.7200 per share expiring on November 27, 2027, and options over 83 Ordinary Shares at an exercise price of $316.8000 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives, including 7,500 Ordinary Shares issuable from 2,500 restricted share units vesting through October 10, 2028, and 28,333 Ordinary Shares issuable from other restricted share units vesting in 34 monthly installments through January 1, 2029.
Wearable Devices Ltd. Chief Executive Officer Asher Dahan filed an initial Form 3, reporting his current equity stake in the company. He directly holds 72,708 Ordinary Shares, reflecting his existing ownership position as of the filing date.
In addition, Dahan holds stock options over 125 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033, and options over 208 Ordinary Shares at an exercise price of $104.16 per share expiring on September 26, 2034. Footnotes state that his holdings include 6,250 Ordinary Shares issuable upon vesting of RSUs in monthly installments through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of RSUs in monthly installments through January 1, 2029, with each RSU representing one Ordinary Share.
Wearable Devices Ltd. Chief Executive Officer Asher Dahan filed an initial Form 3, reporting his current equity stake in the company. He directly holds 72,708 Ordinary Shares, reflecting his existing ownership position as of the filing date.
In addition, Dahan holds stock options over 125 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033, and options over 208 Ordinary Shares at an exercise price of $104.16 per share expiring on September 26, 2034. Footnotes state that his holdings include 6,250 Ordinary Shares issuable upon vesting of RSUs in monthly installments through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of RSUs in monthly installments through January 1, 2029, with each RSU representing one Ordinary Share.
Wearable Devices Ltd. filed an initial ownership report for Chief Technology Officer Langer Leeor Jacob. He directly holds 72,917 Ordinary Shares and stock options to acquire 125 additional Ordinary Shares at an exercise price of 316.8 per share, expiring on August 23, 2033.
The filing notes 6,250 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,042 shares through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,389 shares through January 1, 2029.
Wearable Devices Ltd. filed an initial ownership report for Chief Technology Officer Langer Leeor Jacob. He directly holds 72,917 Ordinary Shares and stock options to acquire 125 additional Ordinary Shares at an exercise price of 316.8 per share, expiring on August 23, 2033.
The filing notes 6,250 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,042 shares through September 10, 2026, and 47,222 Ordinary Shares issuable upon vesting of restricted share units in equal monthly installments of 1,389 shares through January 1, 2029.
Wearable Devices Ltd. executive Remez Offir has filed an initial Form 3 showing his equity holdings in the company. The filing reports direct ownership of 25,417 Ordinary Shares as of the reporting date, establishing his baseline stake as Executive VP of Business Development.
Offir also holds stock options over 571 Ordinary Shares at an exercise price of $0.72 per share expiring on November 1, 2031, and options over 83 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives through restricted share units: 2,500 Ordinary Shares vesting in equal monthly installments of 417 shares through September 10, 2026, and 16,528 Ordinary Shares vesting in equal monthly installments of 486 shares through January 1, 2029, with each RSU convertible into one Ordinary Share.
Wearable Devices Ltd. executive Remez Offir has filed an initial Form 3 showing his equity holdings in the company. The filing reports direct ownership of 25,417 Ordinary Shares as of the reporting date, establishing his baseline stake as Executive VP of Business Development.
Offir also holds stock options over 571 Ordinary Shares at an exercise price of $0.72 per share expiring on November 1, 2031, and options over 83 Ordinary Shares at an exercise price of $316.80 per share expiring on November 30, 2033. Footnotes indicate additional equity incentives through restricted share units: 2,500 Ordinary Shares vesting in equal monthly installments of 417 shares through September 10, 2026, and 16,528 Ordinary Shares vesting in equal monthly installments of 486 shares through January 1, 2029, with each RSU convertible into one Ordinary Share.
Wearable Devices Ltd. director Ilana Lurie filed an initial ownership report showing her equity stake in the company. She directly holds 37,500 Ordinary Shares. This amount includes 7,500 shares issuable from 2,500 restricted share units (RSUs) that begin vesting on October 10, 2026 and then in equal monthly installments through October 10, 2028, and 28,333 shares issuable from RSUs vesting in equal monthly installments of 833 shares through January 1, 2029, with each RSU representing one Ordinary Share.
She also holds a stock option covering 83 Ordinary Shares at an exercise price of 316.8000, which was granted on November 30, 2023, vests in monthly installments after an initial vesting on August 23, 2024, and expires on November 30, 2033.
Wearable Devices Ltd. director Ilana Lurie filed an initial ownership report showing her equity stake in the company. She directly holds 37,500 Ordinary Shares. This amount includes 7,500 shares issuable from 2,500 restricted share units (RSUs) that begin vesting on October 10, 2026 and then in equal monthly installments through October 10, 2028, and 28,333 shares issuable from RSUs vesting in equal monthly installments of 833 shares through January 1, 2029, with each RSU representing one Ordinary Share.
She also holds a stock option covering 83 Ordinary Shares at an exercise price of 316.8000, which was granted on November 30, 2023, vests in monthly installments after an initial vesting on August 23, 2024, and expires on November 30, 2033.
Wearable Devices Ltd. director Nir Yaacov filed an initial insider ownership report on Form 3. The filing lists him as a director of the company but does not report any share transactions or derivative positions, indicating this is a baseline disclosure rather than a trading event.
Wearable Devices Ltd. director Nir Yaacov filed an initial insider ownership report on Form 3. The filing lists him as a director of the company but does not report any share transactions or derivative positions, indicating this is a baseline disclosure rather than a trading event.
Wearable Devices Ltd. Chief Financial Officer Mualem Alon filed an initial Form 3 reporting his existing equity position. He directly holds 52,083 Ordinary Shares and has stock options covering 417 shares at an exercise price of $0.7200 expiring on January 23, 2032 and 83 shares at $316.8000 expiring on November 30, 2033. Footnotes also describe RSU awards for 5,000 Ordinary Shares vesting monthly through September 10, 2026 and 37,778 Ordinary Shares vesting monthly through January 1, 2029, each RSU representing one Ordinary Share.
Wearable Devices Ltd. Chief Financial Officer Mualem Alon filed an initial Form 3 reporting his existing equity position. He directly holds 52,083 Ordinary Shares and has stock options covering 417 shares at an exercise price of $0.7200 expiring on January 23, 2032 and 83 shares at $316.8000 expiring on November 30, 2033. Footnotes also describe RSU awards for 5,000 Ordinary Shares vesting monthly through September 10, 2026 and 37,778 Ordinary Shares vesting monthly through January 1, 2029, each RSU representing one Ordinary Share.
Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed an initial ownership report showing direct holdings in the company’s ordinary shares and equity awards. The filing lists 23,667 Ordinary Shares, which include RSUs for 2,500 shares vesting in monthly installments of 417 shares through September 10, 2026 and RSUs for 16,056 shares vesting in monthly installments of 472 shares through January 1, 2029. Fleisher also holds stock options over 125 ordinary shares at an exercise price of 158.4000, expiring on December 15, 2032, and options over 63 ordinary shares at an exercise price of 316.8000, expiring on November 30, 2033. These entries reflect existing positions rather than new market purchases or sales.
Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed an initial ownership report showing direct holdings in the company’s ordinary shares and equity awards. The filing lists 23,667 Ordinary Shares, which include RSUs for 2,500 shares vesting in monthly installments of 417 shares through September 10, 2026 and RSUs for 16,056 shares vesting in monthly installments of 472 shares through January 1, 2029. Fleisher also holds stock options over 125 ordinary shares at an exercise price of 158.4000, expiring on December 15, 2032, and options over 63 ordinary shares at an exercise price of 316.8000, expiring on November 30, 2033. These entries reflect existing positions rather than new market purchases or sales.
Wearable Devices Ltd. reported full-year 2025 results showing early revenue growth but continued losses. Revenue rose to $647 thousand from $522 thousand, helped by a 28.5% increase in sales of its Mudra Link and Mudra Band gesture-control products.
The company remained unprofitable, with an operating loss of $8.3 million and a net loss of $8.1 million. During 2025 it raised approximately $24.4 million in gross proceeds from equity offerings, ending the year with a cash balance of $6.5 million and short-term deposits of $11.9 million, for total current assets of $19.5 million. Total liabilities fell to $1.4 million after repaying a convertible note, and shareholders’ equity increased to $18.6 million.
Wearable Devices Ltd. reported full-year 2025 results showing early revenue growth but continued losses. Revenue rose to $647 thousand from $522 thousand, helped by a 28.5% increase in sales of its Mudra Link and Mudra Band gesture-control products.
The company remained unprofitable, with an operating loss of $8.3 million and a net loss of $8.1 million. During 2025 it raised approximately $24.4 million in gross proceeds from equity offerings, ending the year with a cash balance of $6.5 million and short-term deposits of $11.9 million, for total current assets of $19.5 million. Total liabilities fell to $1.4 million after repaying a convertible note, and shareholders’ equity increased to $18.6 million.